Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-26,970
Closed -$6.2M 62
2020
Q4
$6.2M Buy
26,970
+85
+0.3% +$19.6K 2.68% 20
2020
Q3
$6.83M Sell
26,885
-600
-2% -$149K 3.32% 10
2020
Q2
$6.48M Sell
27,485
-655
-2% -$149K 3.28% 14
2020
Q1
$5.71M Buy
28,140
+899
+3% +$196K 3.63% 10
2019
Q4
$6.57M Sell
27,241
-610
-2% -$134K 3.56% 7
2019
Q3
$5.39M Sell
27,851
-160
-0.6% -$30.7K 3.34% 13
2019
Q2
$5.16M Buy
28,011
+50
+0.2% +$8.95K 3.07% 18
2019
Q1
$5.31M Sell
27,961
-1,600
-5% -$306K 3.03% 18
2018
Q4
$5.75M Sell
29,561
-50
-0.2% -$9.76K 3.48% 11
2018
Q3
$6.14M Buy
29,611
+135
+0.5% +$26.6K 3.3% 14
2018
Q2
$5.44M Sell
29,476
-1,883
-6% -$333K 3.12% 15
2018
Q1
$5.35M Buy
31,359
+513
+2% +$94.2K 2.92% 14
2017
Q4
$5.36M Buy
30,846
+235
+0.8% +$41.6K 2.79% 15
2017
Q3
$5.71M Sell
30,611
-670
-2% -$119K 3.34% 12
2017
Q2
$5.39M Buy
31,281
+240
+0.8% +$39K 3.06% 16
2017
Q1
$5.09M Sell
31,041
-13,869
-31% -$2.3M 2.96% 17
2016
Q4
$6.57M Buy
44,910
+1,455
+3% +$219K 4.13% 6
2016
Q3
$7.25M Buy
43,455
+45
+0.1% +$7.61K 5.01% 3
2016
Q2
$6.6M Sell
43,410
-455
-1% -$70.7K 4.92% 3
2016
Q1
$6.58M Sell
43,865
-1,895
-4% -$282K 5.18% 5
2015
Q4
$7.43M Sell
45,760
-470
-1% -$73.9K 5.42% 1
2015
Q3
$6.39M Buy
46,230
+2,115
+5% +$333K 4.54% 1
2015
Q2
$6.77M Buy
44,115
+295
+0.7% +$47.3K 4.6% 2
2015
Q1
$7M Buy
43,820
+1,235
+3% +$195K 4.76% 3
2014
Q4
$6.78M Buy
42,585
+2,965
+7% +$462K 4.62% 3
2014
Q3
$5.57M Sell
39,620
-2,745
-6% -$358K 4.13% 3
2014
Q2
$5.01M Buy
42,365
+2,520
+6% +$292K 3.71% 4
2014
Q1
$4.91M Sell
39,845
-2,715
-6% -$329K 3.89% 3
2013
Q4
$4.86M Buy
42,560
+1,135
+3% +$129K 3.87% 3
2013
Q3
$4.64M Sell
41,425
-800
-2% -$86.7K 3.93% 5
2013
Q2
$4.17M Buy
+42,225
New +$4.38M 3.98% 3

Other funds holding AMGN

F&V Capital Management's AMGN Position: Q1 2021 in Review

F&V Capital Management sold out of Amgen (AMGN) in Q1 2021, closing a stake of 26,970 shares — an estimated $6.2M sold.

F&V Capital Management first reported a position in AMGN in Q2 2013 and held it in 31 quarters. The position peaked at $7.43M in Q4 2015. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • F&V Capital Management reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
  • F&V Capital Management sold 26,970 Amgen shares in Q1 2021, an estimated $6.2M.
  • F&V Capital Management first reported a position in Amgen in Q2 2013 and held it in 31 quarters.
  • F&V Capital Management's Amgen position peaked at $7.43M in Q4 2015.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on F&V Capital Management's 13F filing for Q1 2021, filed 8 Apr 2021.